HKU COVID-19 vaccine trials to start in July
Share - WeChat
A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- China planning to raise age limit for blood donors, shorten the minimum interval
- Breakthrough in BMI tech aids patients
- Chinese technique for making ultrathin metal films named top 10 scientific breakthroughs
- Former senior political advisor of Sichuan sentenced to 14 years
- Beijing has undergone dramatic improvements since 2017's revamped development plans
- AI open alliance launched to pool resources for innovation and application
































